LobbyingAccutar Biotechnology lobbying by quarter
Accutar Biotechnology's latest lobbying report covers Q2 2026, at $170K. The four quarters Q4 2025–Q3 2026 total $510K. Its first report covers Q4 2025; the issues it reports most are Copyright/Patent/Trademark.
Accutar Biotechnology
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $510K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2025 | $170K | 1 |
| Q1 2026 | $170K | 1 |
| Q2 2026 | $170K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Copyright, patent and trademark$510K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Justice, Dept of (DOJ)3 reports
Firms it paid
| Firm | ||
|---|---|---|
| Ballard Partners | $510K | 3 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JUSTIN J. SAYFIE | Commissioner, Commission on White House Fellows | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/18for Q2 | Ballard Partners | $170K |
| 04/14for Q1 | Ballard Partners | $170K |
| 01/12for Q4 2025 | Ballard Partners | $170K |
| 25/11/26for Q4 2025 | Ballard Partners | Under $5,000 |